Amlodipine and olmesartan Medoxomil (Ascend Laboratories, LLC)
Welcome to the PulseAid listing for the Amlodipine and olmesartan Medoxomil drug offered from Ascend Laboratories, LLC. This Angiotensin 2 Receptor Antagonists [MoA],Angiotensin 2 Receptor Blocker [EPC],Calcium Channel Antagonists [MoA],Dihydropyridine Calcium Channel Blocker [EPC],Dihydropyridines [Chemical/Ingredient] pharmaceutical is classified as a HUMAN PRESCRIPTION DRUG. Below, you can view details for this drug, such as its dosage form, route of delivery, start market/end market dates, and more. We have also randomly listed additional pharmaceuticals used in the same HUMAN PRESCRIPTION DRUG drug type category.
| LABELER NAME / MANUFACTURER: | Ascend Laboratories, LLC |
| NON-PROPRIETARY NAME: | Amlodipine and olmesartan Medoxomil |
| SUBSTANCE NAME: | AMLODIPINE BESYLATE; OLMESARTAN MEDOXOMIL |
| TYPE: | HUMAN PRESCRIPTION DRUG |
| PHARMA CLASS: | Angiotensin 2 Receptor Antagonists [MoA],Angiotensin 2 Receptor Blocker [EPC],Calcium Channel Antagonists [MoA],Dihydropyridine Calcium Channel Blocker [EPC],Dihydropyridines [Chemical/Ingredient] |
| ROUTE: | ORAL |
| DOSAGE FORM: | TABLET |
| MARKETING CATEGORY NAME: | ANDA |
| START MARKETING DATE: | 2017-08-14 |
| END MARKETING DATE: | 0000-00-00 |
Amlodipine and olmesartan Medoxomil HUMAN PRESCRIPTION DRUG Details:
| Item Description | Amlodipine and olmesartan Medoxomil from Ascend Laboratories, LLC |
| LABELER NAME: | Ascend Laboratories, LLC |
| DEA SCHEDULE: |
|
| ACTIVE STRENGTH: | 5; 20(mg/1; mg/1) |
| START MARKETING DATE: | 2017-08-14 |
| END MARKETING DATE: | 0000-00-00 |
| PRODUCT ID: | 67877-499_0b2373f3-3db3-4b6b-a999-1f7ab4fbbe38 |
| PRODUCT NDC: | 67877-499 |
| APPLICATION NUMBER: | ANDA209042 |
Other AMLODIPINE BESYLATE; OLMESARTAN MEDOXOMIL Pharmaceutical Manufacturers / Labelers:
